Vertex Pharmaceuticals Inc. buy EPG2026
Start price
27.01.13
/
50%
€34.73
Target price
19.04.13
€40.00
Performance (%)
85.13%
End price
19.04.13
€64.30
Summary
This prediction ended on 19.04.13 with a price of €64.30. The BUY prediction by EPG2026 for Vertex Pharmaceuticals Inc. saw massive gains of 85.13%. EPG2026 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -2.054% | -2.054% | -15.088% | 21.831% |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% | 49.858% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% | 100.330% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% | 65.355% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% | 68.657% |
Comments by EPG2026 for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Sehr gute Biotechaktie
Vertex Pharma hat gute Produkte in der Pipeline
(Vom Mitglied beendet)

